Sunshine Biopharma Inc (NASDAQ: SBFM) kicked off on Tuesday, down -6.12% from the previous trading day, before settling in for the closing price of $1.96. Over the past 52 weeks, SBFM has traded in a range of $1.17-$3.90.
During the last 5-year period, the sales growth of Healthcare Sector giant was 82.07%. While this was happening, its average annual earnings per share was recorded 88.66%. With a float of $4.55 million, this company’s outstanding shares have now reached $4.56 million.
Sunshine Biopharma Inc (SBFM) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Sunshine Biopharma Inc is 0.08%, while institutional ownership is 5.98%.
Sunshine Biopharma Inc (SBFM) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.94 earnings per share (EPS), higher than consensus estimate (set at -535) by 534.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 88.66% per share during the next fiscal year.
Sunshine Biopharma Inc (NASDAQ: SBFM) Trading Performance Indicators
Take a look at Sunshine Biopharma Inc’s (SBFM) current performance indicators. Last quarter, stock had a quick ratio of 2.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.61, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach 0.33 in one year’s time.
Technical Analysis of Sunshine Biopharma Inc (SBFM)
Looking closely at Sunshine Biopharma Inc (NASDAQ: SBFM), its last 5-days average volume was 2.22 million, which is a jump from its year-to-date volume of 0.71 million. As of the previous 9 days, the stock’s Stochastic %D was 25.12%.
During the past 100 days, Sunshine Biopharma Inc’s (SBFM) raw stochastic average was set at 45.37%, which indicates a significant increase from 36.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1751 in the past 14 days, which was higher than the 0.0987 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5867, while its 200-day Moving Average is $1.7666. However, in the short run, Sunshine Biopharma Inc’s stock first resistance to watch stands at $2.0467. Second resistance stands at $2.2533. The third major resistance level sits at $2.3767. If the price goes on to break the first support level at $1.7167, it is likely to go to the next support level at $1.5933. Should the price break the second support level, the third support level stands at $1.3867.
Sunshine Biopharma Inc (NASDAQ: SBFM) Key Stats
The company with the Market Capitalisation of 8.38 million has total of 4,906K Shares Outstanding. Its annual sales at the moment are 34,870 K in contrast with the sum of -5,130 K annual income. Company’s last quarter sales were recorded 9,410 K and last quarter income was -1,770 K.
